A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2353553
The present invention relates to a method for the treatment of cerebral ischaemia and a drug for the treatment of cerebral ischaemia in particular in humans, as occurs for example in the case of stroke patients. It was found surprisingly that peripheral administering of erythropoietin to the cerebral tissue affected by the ischaemia has a distinctly protective effect. Erythropoietin has the effect thereby that the region of the cerebral tissue which is damaged permanently, in particular in the penumbra, is dramatically reduced relative to conventional measures in the case of cerebral ischaemia without erythropoietin administration.
L'invention concerne une méthode et un moyen permettant de traiter, notamment chez l'homme, les ischémies cérébrales telles que celles qui surviennent chez les patients atteints d'un accident vasculaire cérébral. Etonnamment, il s'est avéré que l'administration périphérique d'érythropoïétine a un effet protecteur marqué sur les tissus cérébraux touchés par l'ischémie. L'érythropoïétine diminue notablement la surface de tissu cérébral définitivement lésé, notamment au niveau de la pénombre, par rapport aux résultats obtenus avec les mesures habituelles sans administration d'érythropoiétine.
Ehrenreich Hannelore
Gleiter Christoph
Ehrenreich Hannelore
Gleiter Christoph
Marks & Clerk
LandOfFree
Method for the treatment of cerebral ischaemia and use of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of cerebral ischaemia and use of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of cerebral ischaemia and use of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1832059